Approaching the asymptote? Evolution and revolution in immunology, Cold Spring Harb Symp Quant Biol, vol.54, pp.1-13, 1989. ,
The type II secretion system: biogenesis, molecular architecture and mechanism, Nat Rev Microbiol, issue.2, 2012. ,
,
Type III protein secretion systems in bacterial pathogens of animals and plants, Microbiol Mol Biol Rev MMBR. juin, vol.62, issue.2, pp.379-433, 1998. ,
Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiol Read Engl, vol.147, pp.2659-69, 2001. ,
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S, Infect Immun. févr, vol.65, issue.2, pp.579-86, 1997. ,
Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway, Mol Microbiol. déc, vol.22, issue.5, pp.991-1003, 1996. ,
Molecular mechanisms of the cytotoxicity of ADPribosylating toxins, Annu Rev Microbiol, vol.62, pp.271-88, 2008. ,
A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells, Infect Immun. déc, vol.73, issue.12, pp.7938-7983, 2005. ,
Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles, J Biol Chem. 27 avr, vol.282, issue.17, pp.13022-13054, 2007. ,
The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via smallmolecular-weight GTP-binding proteins, Mol Microbiol. avr, vol.32, issue.2, pp.393-401, 1999. ,
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases, J Biol Chem. 17 déc, vol.274, issue.51, pp.36369-72, 1999. ,
Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages, Infect Immun. sept, vol.71, issue.9, pp.5296-305, 2003. ,
Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells, Mol Microbiol, vol.30, issue.4, pp.751-760, 1998. ,
Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function, Infect Immun. sept, vol.69, issue.9, pp.5318-5346, 2001. ,
Pseudomonas aeruginosa mediated apoptosis requires the ADP-ribosylating activity of exoS. Microbiol Read Engl, vol.146, pp.2531-2572, 2000. ,
Expression of Pseudomonas aeruginosa Toxin ExoS Effectively Induces Apoptosis in Host Cells, Infect Immun. 1 déc, vol.74, issue.12, pp.6557-70, 2006. ,
Type II Secretion System of Pseudomonas aeruginosa: In Vivo Evidence of a Significant Role in Death Due to Lung Infection, J Infect Dis. 15 mai, vol.203, issue.10, pp.1369-77, 2011. ,
Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment, J Bacteriol. avr, vol.185, issue.7, pp.2080-95, 2003. ,
Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU, Cell Microbiol. déc, vol.7, issue.12, pp.1811-1833, 2005. ,
The growing phospholipase A2 superfamily of signal transduction enzymes, Trends Biochem Sci. janv, vol.22, issue.1, pp.1-2, 1997. ,
Properties of the Group IV phospholipase A2 family, Prog Lipid Res, vol.45, issue.6, pp.487-510, 2006. ,
Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU, Microbes Infect. févr, vol.8, issue.2, pp.450-459, 2006. ,
Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells, Microb Pathog. juill, vol.45, issue.1, pp.30-37, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00415881
Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life, Am J Respir Crit Care Med. 1 juin, vol.183, issue.11, pp.1463-71, 2011. ,
The changing microbial epidemiology in cystic fibrosis, Clin Microbiol Rev. avr, vol.23, issue.2, pp.299-323, 2010. ,
Identification of the cystic fibrosis gene: genetic analysis, Science. 8 sept, vol.245, issue.4922, pp.1073-80, 1989. ,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science. 8 sept, vol.245, issue.4922, pp.1066-73, 1989. ,
Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening, Hum Mutat. juin, vol.19, issue.6, pp.575-606, 2002. ,
Cystic fibrosis infections: treatment strategies and prospects, FEMS Microbiol Lett, vol.300, issue.2, pp.153-64, 2009. ,
Lower airway inflammation in infants and young children with cystic fibrosis, Am J Respir Crit Care Med, vol.156, issue.4, pp.1197-204, 1997. ,
Microbial ecology of the cystic fibrosis lung, Microbiol Read Engl. avr, vol.153, pp.917-940, 2007. ,
Respiratory microbiology of patients with cystic fibrosis in the United States, Chest. déc, vol.136, issue.6, pp.1554-60, 1995. ,
Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity, Nat Commun, vol.5, p.5105, 2014. ,
Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases, Curr Mol Med. déc, vol.1, issue.6, pp.739-54, 2001. ,
Antibacterial actions of secreted phospholipases A2. Review, Biochim Biophys Acta. févr, vol.1781, issue.1-2, pp.1-9, 2008. ,
Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppellike factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y. Infect Immun, vol.74, pp.5893-902, 2006. ,
Mammalian Krüppel-like factors in health and diseases, Physiol Rev, vol.90, issue.4, pp.1337-81, 2010. ,
KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation, J Exp Med. 17 mai, vol.199, issue.10, pp.1305-1320, 2004. ,
Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes, Proc Natl Acad Sci, vol.103, issue.17, pp.6653-6661, 2006. ,
Abrogation of anti-inflammatory transcription factor LKLF in neutrophildominated airways, Am J Respir Cell Mol Biol. juin, vol.38, issue.6, pp.679-88, 2008. ,
Bacterial toxins induce sustained mRNA expression of the silencing transcription factor klf2 via inactivation of RhoA and Rhophilin 1, Infect Immun. déc, vol.77, issue.12, pp.5583-92, 2009. ,
The type III secretion system of Pseudomonas aeruginosa: infection by injection, Nat Rev Microbiol. sept, vol.7, issue.9, pp.654-65, 2009. ,
Secreted Group IIA Phospholipase A2 Protects Humans Against the Group B Streptococcus: Experimental and Clinical Evidence, J Infect Dis. 15 déc, vol.208, issue.12, pp.2025-2060, 2013. ,
Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome, Crit Care Med. avr, vol.33, issue.4, pp.772-781, 2005. ,
The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin, Am J Respir Cell Mol Biol. juin, vol.28, issue.6, pp.738-783, 2003. ,
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa, Proc Natl Acad Sci, vol.103, issue.52, pp.19890-19895, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00820015
Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance, J Med Microbiol. avr, vol.34, issue.4, pp.213-220, 1991. ,